[1]曹 江,杨麦青,葛 莉,等.宫颈癌组织中DEK与MMP-7、N-cadherin的表达及临床意义[J].医学信息,2024,37(02):95-98.[doi:10.3969/j.issn.1006-1959.2024.02.017]
 CAO Jiang,YANG Mai-qing,GE Li,et al.The Expression and Clinical Significance of DEK, MMP-7 and N-cadherin in Cervical Carcinoma[J].Journal of Medical Information,2024,37(02):95-98.[doi:10.3969/j.issn.1006-1959.2024.02.017]
点击复制

宫颈癌组织中DEK与MMP-7、N-cadherin的表达及临床意义()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年02期
页码:
95-98
栏目:
论著
出版日期:
2024-01-15

文章信息/Info

Title:
The Expression and Clinical Significance of DEK, MMP-7 and N-cadherin in Cervical Carcinoma
文章编号:
1006-1959(2024)02-0095-04
作者:
曹 江杨麦青葛 莉
(1.潍坊市中医院妇产科,山东 潍坊 261041;2.潍坊市人民医院病理科,山东 潍坊 261041;3.潍坊市中医院脑病科,山东 潍坊 261041)
Author(s):
CAO JiangYANG Mai-qingGE Liet al.
(1.Department of Obstetrics and Gynecology,Weifang Hospital of Traditional Chinese Medicine,Weifang 261041,Shandong,China;2.Department of Pathology,Weifang People’s Hospital,Weifang 261041,Shandong,China;3.Department of Encephalopathy,Weifang Hospital of Traditional Chinese Medicine,Weifang 261041,Shandong,China)
关键词:
宫颈癌DEKMMP-7N-cadherin
Keywords:
Cervical carcinomaDEKMMP-7N-caherin
分类号:
R737.33
DOI:
10.3969/j.issn.1006-1959.2024.02.017
文献标志码:
A
摘要:
目的 观察宫颈癌组织中DEK与MMP-7、N-cadherin的表达情况,并探讨其在宫颈癌的临床意义。方法 收集2016年1月-2021年12月在潍坊市中医院手术切除,并经病理确诊为宫颈鳞状细胞癌组织80例,选取癌旁正常宫颈组织标本50例,采用免疫组化法检测两组中DEK与MMP-7、N-caherin蛋白的表达情况,分析三者与宫颈癌临床病理特征的关系,并进一步分析三种蛋白在宫颈癌中表达的相关性。结果 DEK、MMP-7、N-cadherin在宫颈癌组织中的表达高于癌旁正常宫颈组织(P<0.05);DEK与MMP-7、N-caherin的高表达与宫颈癌分化程度、淋巴结转移及TNM分期相关(P<0.05),与宫颈癌患者年龄、肿瘤大小均无关(P>0.05)。宫颈癌中DEK的表达分别与MMP-7(r=0.269,P=0.008)、N-caherin(r=0.295,P=0.004)的表达呈正相关。结论 DEK与宫颈癌的发生有关,且与宫颈癌的组织分化及浸润转移有关,其在宫颈癌中的作用机制可能与MMP-7、N-caherin有关。
Abstract:
Objective To observe the expression of DEK, MMP-7 and N-cadherin in cervical carcinoma, and to explore their clinical significance.Methods From January 2016 to December 2021, 80 cases of cervical squamous cell carcinoma tissues and 50 cases of adjacent normal cervical tissues were collected from Weifang Hospital of Traditional Chinese Medicine. The expression of DEK, MMP-7 and N-caherin proteins in the two groups was detected by immunohistochemistry. The relationship between the three proteins and the clinicopathological characteristics of cervical cancer was analyzed, and the correlation between the expression of the three proteins in cervical cancer was further analyzed.Results The expression of DEK, MMP-7 and N-cadherin in cervical cancer tissues was higher than that in adjacent normal cervical tissues (P<0.05). The high expression of DEK, MMP-7 and N-caherin was related to the degree of differentiation, lymph node metastasis and TNM stage of cervical cancer (P<0.05), but not to the age and tumor size of cervical cancer patients (P>0.05). The expression of DEK in cervical cancer was positively correlated with the expression of MMP-7 (r=0.269, P=0.008) and N-caherin (r=0.295, P=0.004).Conclusion DEK is related to the occurrence of cervical cancer, and is related to the tissue differentiation, invasion and metastasis of cervical cancer. Its mechanism of action in cervical cancer may be related to MMP-7 and N-caherin.

参考文献/References:

[1]Siegel RL,Miller KD,Fuchs HE,et al.Cancer Statistics,2021[J].CA Cancer J Clin,2021,71(1):7-33.[2]Mitra T,Elangovan S.Cervical cancer development,chemoresistance, and therapy: a snapshot of involvement of microRNA[J].Mol Cell Biochem,2021,476(12):4363-4385.[3]付小玲,郭哲,许静.cAMP/PKA通路在HPV16/18相关宫颈癌中的表达情况及临床意义[J].实用癌症杂志,2023,38(2):227-230.[4]He WQ,Li C.Recent global burden of cervical cancer incidence and mortality, predictors, and temporal trends[J].Gynecol Oncol,2021,163(3):583-592.[5]张璐,隋龙.中国21~24岁女性宫颈癌筛查现状及应对困扰[J].现代妇产科进展,2021,30(12):951-953.[6]李宏,高蓓,王媛.1990-2019年我国宫颈癌疾病负担变化趋势分析[J].中国慢性病预防与控制,2022,30(9):672-675,681.[7]王静,杜欣,黄燕明,等.宫颈癌高危型HPV感染的影响因素与ERK1/2信号通路关键因子[J].中华医院感染学杂志,2023,33(4):593-597.[8]刘敏,缪华珍,黄菁.G蛋白偶联受体4、Ki-67、生存素与高危HPV感染的相关性及诊断宫颈癌价值[J].中国计划生育学杂志,2022,30(12):2866-2869,2874.[9]张艳霞,闫燕艳,邓亮,等.E-钙黏素和N-钙黏素在胃肠道间质瘤中的表达及其临床意义[J].山西大同大学学报(自然科学版),2023,39(1):80-83.[10]张继东,王童玉,朱绪锋.原发性肝癌组织中钙黏蛋白和P63蛋白表达情况及意义[J].中国卫生工程学,2022,21(6):1009-1011.[11]Ke W,Ma L,Wang B,et al.N-cadherin mimetic hydrogel enhances MSC chondrogenesis through cell metabolism[J].Acta Biomater,2022,150:83-95.[12]赵春华,赵慧君,安娜,等.脑胶质瘤患者术后肺部感染情况及血清MMP、IGF水平的变化[J].中国现代医药杂志,2022,24(11):22-25.[13]陈浩,白利君,于超.术前LSR、D-Dime及MMP-9联合检测在胃癌根治术预后中的评估价值[J].分子诊断与治疗杂志,2022,14(11):2001-2004.[14]Kovács PT,Mayer T,Csizmarik A,et al.Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma[J].Biomedicines,2022,10(3):698.[15]Capitano ML,Sammour Y,Ropa J,et al.DEK, a nuclear protein, is chemotactic for hematopoietic stem/progenitor cells acting through CXCR2 and Gαi signaling[J].J Leukoc Biol,2022,112(3):449-456.[16]Yang YS,Jia XZ,Lu QY,et al.Exosomal DEK removes chemoradiotherapy resistance by triggering quiescence exit of breast cancer stem cells[J].Oncogene,2022,41(18):2624-2637.[17]Hacker KE,Bolland DE,Tan L,et al.The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival[J].Neoplasia,2018,20(12):1209-1218.[18]宋艺兰,王知广,姜京植,等.靶向DEK适配体DTA-64可通过阻断TGF-β1信号通路抑制支气管哮喘小鼠气道上皮细胞的上皮间质转化[J].细胞与分子免疫学杂志,2022,38(2):103-109.[19]Ishida K,Nakashima T,Shibata T,et al.Role of the DEK oncogene in the development of squamous cell carcinoma[J].Int J Clin Oncol,2020,25(9):1563-1569.[20]Cai Y,Hao Y,Xu H,et al.Gigantol inhibits cell proliferation and induces apoptosis by regulating DEK in non-small cell lung cancer[J].Exp Ther Med,2021,22(5):1317.[21]Yang MQ,Bai LL,Wang Z,et al.DEK is highly expressed in breast cancer and is associated with malignant phenotype and progression[J].Oncol Lett,2021,21(6):440.

相似文献/References:

[1]廖加群,曹 雪,陈燕平,等.宫颈癌盆腔淋巴结转移分布及危险因素分析[J].医学信息,2018,31(03):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
 LIAO Jia-qun,CAO Xue,CHEN Yan-ping,et al.Distribution and Risk Factors of Pelvic Lymph Node Metastasis in Cervical Cancer[J].Journal of Medical Information,2018,31(02):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
[2]徐 洁.宫颈癌筛查及预防的研究进展[J].医学信息,2018,31(09):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
 XU Jie.Advances in Screening and Prevention of Cervical Cancer[J].Journal of Medical Information,2018,31(02):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
[3]黄 花,徐冬冬,章丽霞.TGF-β1在宫颈癌中的研究进展[J].医学信息,2018,31(12):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
 HUANG Hua,XU Dong-dong,ZHANG Li-xia.Research Progress of TGF-β1 in Cervical Cancer[J].Journal of Medical Information,2018,31(02):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
[4]夏易曼娜,李虎成.腹腔镜下宫颈癌根治术与传统开腹手术的对比研究[J].医学信息,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
 XIA Yi-manna,LI Hu-cheng.Comparative Study of Laparoscopic Radical Resection of Cervical Cancer and Traditional Open Surgery[J].Journal of Medical Information,2018,31(02):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
[5]杨 军,王翠平,李 龙,等.义安区体检HPV-DNA筛查结果分析[J].医学信息,2018,31(14):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
 YANG Jun,WANG Cui-ping,LI Long,et al.Analysis of the Results of HPV-DNA Screening in the Medical Examination of Yian District[J].Journal of Medical Information,2018,31(02):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
[6]王双英,张 娜,刘 芳.具有高危复发因素的早期宫颈癌术后辅助治疗进展[J].医学信息,2018,31(15):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
 WANG Shuang-ying,ZHANG Na,LIU Fang.Advances in Postoperative Adjuvant Therapy for Early Cervical Cancer with High Risk of Recurrence[J].Journal of Medical Information,2018,31(02):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
[7]聂小凤,翟慧慧,冷天艳,等.宫颈脱落细胞miR34a检测在HR-HPV阳性患者 分流中的作用分析[J].医学信息,2018,31(16):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
 NIE Xiao-feng,ZHAI Hui-hui,LENG Tian-yan,et al.Analysis of the Role of MiR34a in Cervical Exfoliated Cells in Shunt of HR-HPV Positive Patients[J].Journal of Medical Information,2018,31(02):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
[8]吴晓玲,周桂华.miR-187在宫颈癌中的表达与临床病理关系的研究[J].医学信息,2018,31(16):69.[doi:10.3969/j.issn.1006-1959.2018.16.019]
 WU Xiao-ling,ZHOU Gui-hua.Expression of miR-187 in Cervical Cancer and Its Relationship with Clinicopathological Features[J].Journal of Medical Information,2018,31(02):69.[doi:10.3969/j.issn.1006-1959.2018.16.019]
[9]夏为书,彭莉贞,钟清玲.我国宫颈癌患者配偶生活质量评价的研究现状[J].医学信息,2018,31(23):41.[doi:10.3969/j.issn.1006-1959.2018.23.012]
 XIA Wei-shu,PENG Li-zhen,ZHONG Qing-ling.Research Status of Spouse Quality of Life Evaluation of Cervical Cancer Patients in China[J].Journal of Medical Information,2018,31(02):41.[doi:10.3969/j.issn.1006-1959.2018.23.012]
[10]邢 均.全身麻醉联合硬膜外麻醉在宫颈癌手术中的应用及效果评价[J].医学信息,2019,32(01):122.[doi:10.3969/j.issn.1006-1959.2019.01.037]
 XING Jun.Application and Evaluation of General Anesthesia Combined with Epidural Anesthesia in[J].Journal of Medical Information,2019,32(02):122.[doi:10.3969/j.issn.1006-1959.2019.01.037]

更新日期/Last Update: 1900-01-01